美国 · SEC FORM 4
CapsoVision, Inc
CV · Nasdaq · CIK 0001378325 · Healthcare · Medical Devices
内部人信号
1 位买方 · 5 条买入交易行 · $11.0M 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是:TenPercentOwner(CEO、董事长和持股 10% 以上的股东得分最低)
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 60.7
- 60.6
- 60.5
- 60.4
- 60.1
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- +1.1%
- 3M
- +5.9%
- 6M
- +5.4%
- 12M
- +43.3%
波动率与流动性
- 波动率
- 95.0%
- Beta
- —
- 平均每日成交额
- USD 1.0M
估值
- 市值
- USD 329.8M
- P/E
- —
基本面
- 利润率
- -186.8%
- ROE
- -190.9%
- 细分行业
- Medical Devices
市场数据
价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:市值, 利润率, ROE · 财年截止日:2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-08-12 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 2,104,385
- 上期报告
- 1,899,065
- 日均成交量
- 386,803
- 回补天数
- 5.4
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | HARARI ELIYAHOU ET AL | 买入 (P) | Common Stock | 1,757,469 | USD 5.69 | USD 9,999,999 | SEC 申报 ↗ |
| 2026-09-15 | Shen Ching Hang | 买入 (P) | Common stock | 878,734 | USD 5.69 | USD 4,999,996 | SEC 申报 ↗ |
| 2026-09-15 | Shen Ching Hang | 买入 (P) | Common stock | 878,734 | USD 5.69 | USD 4,999,996 | SEC 申报 ↗ |
| 2026-07-17 | HARARI ELIYAHOU ET AL | 买入 (P) | Common Stock | 61,068 | USD 6.73 | USD 410,988 | SEC 申报 ↗ |
| 2026-07-08 | HARARI ELIYAHOU ET AL | 买入 (P) | Common Stock | 81,300 | USD 6.09 | USD 495,117 | SEC 申报 ↗ |
| 2026-06-26 | HARARI ELIYAHOU ET AL | 买入 (P) | Common Stock | 13,850 | USD 7.35 | USD 101,798 | SEC 申报 ↗ |
| 2025-07-03 | Tsai Chen Lung | 买入 (P) | Common Stock | 20 | USD 4.17 | USD 83 | SEC 申报 ↗ |
Form 4 申报证据
25 transaction lines in the latest 365-day window; 35 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | HARARI ELIYAHOU ET AL | 买入 (P) | Common Stock | 1,757,469 | USD 5.69 | USD 9,999,999 | SEC 申报 ↗ |
| 2026-09-15 | Shen Ching Hang | 买入 (P) | Common stock | 878,734 | USD 5.69 | USD 4,999,996 | SEC 申报 ↗ |
| 2026-09-15 | Shen Ching Hang | 买入 (P) | Common stock | 878,734 | USD 5.69 | USD 4,999,996 | SEC 申报 ↗ |
展开近期 Form 4 证据 (22 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | HARARI ELIYAHOU ET AL | 买入 (P) | Common Stock | 1,757,469 | USD 5.69 | USD 9,999,999 | SEC 申报 ↗ |
| 2026-09-15 | Shen Ching Hang | 买入 (P) | Common stock | 878,734 | USD 5.69 | USD 4,999,996 | SEC 申报 ↗ |
| 2026-09-15 | Shen Ching Hang | 买入 (P) | Common stock | 878,734 | USD 5.69 | USD 4,999,996 | SEC 申报 ↗ |
| 2026-07-17 | HARARI ELIYAHOU ET AL | 买入 (P) | Common Stock | 61,068 | USD 6.73 | USD 410,988 | SEC 申报 ↗ |
| 2026-07-08 | HARARI ELIYAHOU ET AL | 买入 (P) | Common Stock | 81,300 | USD 6.09 | USD 495,117 | SEC 申报 ↗ |
| 2026-06-30 | Tsai Chen Lung | 期权行权/转换 (M) | Common Stock | 2,022 | USD 7.58 | USD 15,327 | SEC 申报 ↗ |
| 2026-06-30 | Kuo Hui Ying | 期权行权/转换 (M) | Common Stock | 2,022 | USD 7.58 | USD 15,327 | SEC 申报 ↗ |
| 2026-06-30 | King Wen-Herng Henry | 期权行权/转换 (M) | Common Stock | 2,022 | USD 7.58 | USD 15,327 | SEC 申报 ↗ |
| 2026-06-30 | Imperial Joanne Carol | 期权行权/转换 (M) | Common Stock | 2,022 | USD 7.58 | USD 15,327 | SEC 申报 ↗ |
| 2026-06-30 | Harari Michele | 期权行权/转换 (M) | Common Stock | 2,022 | USD 7.58 | USD 15,327 | SEC 申报 ↗ |
| 2026-06-30 | GOUW JULIA S | 期权行权/转换 (M) | Common Stock | 2,022 | USD 7.58 | USD 15,327 | SEC 申报 ↗ |
| 2026-06-26 | HARARI ELIYAHOU ET AL | 买入 (P) | Common Stock | 13,850 | USD 7.35 | USD 101,798 | SEC 申报 ↗ |
| 2026-06-08 | Imperial Joanne Carol | 卖出 (S) | Common Stock | 1,200 | USD 7.16 | USD 8,592 | SEC 申报 ↗ |
| 2026-05-05 | Atkinson Douglas Patrick | 期权行权/转换 (M) | Common Stock | 34,786 | USD 0.57 | USD 19,828 | SEC 申报 ↗ |
| 2026-05-04 | Atkinson Douglas Patrick | 期权行权/转换 (M) | Common Stock | 72,571 | USD 0.35 | USD 25,269 | SEC 申报 ↗ |
| 2026-04-17 | Shen Ching Hang | J (J) | Common stock | 3,991,606 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-31 | Tsai Chen Lung | 期权行权/转换 (M) | Common Stock | 2,887 | USD 10.69 | USD 30,862 | SEC 申报 ↗ |
| 2025-12-31 | Kuo Hui Ying | 期权行权/转换 (M) | Common Stock | 2,887 | USD 10.69 | USD 30,862 | SEC 申报 ↗ |
| 2025-12-31 | King Wen-Herng Henry | 期权行权/转换 (M) | Common Stock | 2,887 | USD 10.69 | USD 30,862 | SEC 申报 ↗ |
| 2025-12-31 | Imperial Joanne Carol | 期权行权/转换 (M) | Common Stock | 2,887 | USD 10.69 | USD 30,862 | SEC 申报 ↗ |
| 2025-12-31 | Harari Michele | 期权行权/转换 (M) | Common Stock | 2,887 | USD 10.69 | USD 30,862 | SEC 申报 ↗ |
| 2025-12-31 | GOUW JULIA S | 期权行权/转换 (M) | Common Stock | 2,887 | USD 10.69 | USD 30,862 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CV |
| CIK | 0001378325 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3845 Electromedical & Electrotherapeutic Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 35 transaction lines from 2025-07-03 to 2026-09-18 8 P purchase lines · 1 S sale lines · 26 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.